Renal Assessment for Early Detection of Renal Impairment in Systemic Sclerosis and Systemic Lupus Erythematosus Patients
Conditions: Systemic Sclerosis and Systemic Lupus Erythematous Interventions: Device: Renal multi-parametric MRI, Renal doppler ultrasound, Serum CD147 Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials
Delving Into Participation Trends of Scleroderma Clinical Trials
Conditions: Scleroderma Sponsors: Power Life Sciences Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
Study of Diosmin-Diosmetin for the Treatment of Digital Ulcers in Systemic Sclerosis
Conditions: Sclerosis, Systemic (Scleroderma) With Dital Ulcers Interventions: Other: Diosmin-Diosmetin Sponsors: Primus Pharmaceuticals; KGK Science Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Effects of Fractional CO2 Laser Treatment on Vaginal Symptoms and Sexual Dysfunction in Women With Systemic Sclerosis
Conditions: Systemic Sclerosis; Vulvovaginal Signs and Symptoms; Sexual Function Disturbances Interventions: Device: CO2 Vaginal Laser Sponsors: IRCCS San Raffaele Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
Study to Evaluate the Safety, Tolerability, and Activity of CM-101 in Patients With Systemic Sclerosis
Conditions: Systemic Sclerosis Interventions: Drug: 10 mg/kg CM-101; Drug: Placebo Sponsors: ChemomAb Ltd. Suspended (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials
Platform Clinical Study for Conquering Scleroderma
Conditions: Interstitial Lung Disease Due to Systemic Disease; Scleroderma Interventions: Drug: Amlitelimab; Drug: BI 1015550; Drug: Placebo Sponsors: Scleroderma Research Foundation, Inc.; Sanofi; Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease
Conditions: Systemic Sclerosis Associated Interstitial Lung Disease; Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD); Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) Interventions: Drug: GenSci048; Drug: GenSci048 placebo Sponsors: Changchun GeneScience Pharmaceutical Co., Ltd.; West China Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials
Periodontal Microbiota in Systemic Sclerosis
Conditions: Scleroderma Systemic Interventions: Other: Subgingival dental plaque sampling for whole metagenome sequencing of the periodontal microbiota Sponsors: University Hospital, Strasbourg, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials
Safety and Efficacy of Topical Sodium Metabisulfite for the Treatment of Calcinosis in Patients With Systemic Sclerosis
Conditions: Systemic Sclerosis; Calcinosis Interventions: Drug: Topical 25% sodium metabisulfite (SM) in pediatric cold cream; Drug: Placebo Sponsors: Pontificia Universidad Catolica de Chile; Liga Panamericana de Asociaciones de Reumatologia (PANLAR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101
Conditions: Idiopathic Inflammatory Myopathies; Diffuse Cutaneous Systemic Sclerosis; SLE Nephritis; ANCA Associated Vasculitis Interventions: Drug: KYV-101; Drug: Cyclophosphamide; Drug: Fludarabine Sponsors: David Porter; Kyverna Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
An Open-lable Trial of Subcutaneous Semaglutide in Systemic Scleroderma
Conditions: Scleroderma, Systemic; Fibrosis; Semaglutide Interventions: Drug: Semaglutide Pen Injector Sponsors: Second Xiangya Hospital of Central South University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
Hand Function Impairment in Systemic Sclerosis: Outcomes, Mechanisms and Experience (HANDSOME)
Conditions: Systemic Sclerosis Interventions: Diagnostic Test: Imaging, blood samples, fuctional tests and physical examination Sponsors: UMC Utrecht; University Medical Center Groningen; Radboud University Medical Center; Leiden University Medical Center; Royal Free Hospital NHS Foundation Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
" Pulmonary Rehabilitation Program in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis "
Conditions: Systemic Sclerosis Associated Interstitial Lung Disease Interventions: Procedure: Pulmonary Rehabilitation Program Sponsors: Coordinaci ón de Investigación en Salud, Mexico Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials
The Effect of a Self-Management Program on Individuals With Scleroderma
Conditions: Scleroderma; Systemic Sclerosis Interventions: Behavioral: Self Management Intervention Program Sponsors: Emirhan Karaku ş Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
RY_SW01 Cell Injection Therapy in Systemic Sclerosis
Condition: Systemic Sclerosis Interventions: Drug: RY_SW01 cell injection; Drug: Basic treatment Sponsors: Jiangsu Renocell Biotech Company; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials
